v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024   74,028,786        
Beginning balance at Dec. 31, 2024 $ (32,640) $ 7 $ 591,281 $ (11,774) $ (612,154) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,177)       (1,177)  
Issuance of common stock to directors (in shares)   4,735        
Vesting of restricted stock units (in shares)   167,726        
Vesting of restricted stock units (3,199)   (3,199)      
Exercise of stock options (in shares)   18,953        
Exercise of stock options 190   190      
Stock-based compensation expense 8,814   8,814      
Other comprehensive gain (loss) (3,733)     (3,733)    
Ending balance (in shares) at Mar. 31, 2025   74,220,200        
Ending balance at Mar. 31, 2025 (31,745) $ 7 597,086 (15,507) (613,331) 0
Beginning balance (in shares) at Dec. 31, 2024   74,028,786        
Beginning balance at Dec. 31, 2024 (32,640) $ 7 591,281 (11,774) (612,154) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,489)          
Ending balance (in shares) at Jun. 30, 2025   74,020,688        
Ending balance at Jun. 30, 2025 (53,741) $ 7 605,084 (35,189) (613,643) (10,000)
Beginning balance (in shares) at Mar. 31, 2025   74,220,200        
Beginning balance at Mar. 31, 2025 (31,745) $ 7 597,086 (15,507) (613,331) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (312)       (312)  
Issuance of common stock to directors (in shares)   5,686        
Vesting of restricted stock units (in shares)   77,082        
Vesting of restricted stock units (1,269)   (1,269)      
Exercise of stock options (in shares)   30,880        
Exercise of stock options 314   314      
Repurchase of common stock (in shares)   (313,160)        
Repurchase of common stock (10,000)         (10,000)
Stock-based compensation expense 8,953   8,953      
Other comprehensive gain (loss) (19,682)     (19,682)    
Ending balance (in shares) at Jun. 30, 2025   74,020,688        
Ending balance at Jun. 30, 2025 (53,741) $ 7 605,084 (35,189) (613,643) (10,000)
Beginning balance (in shares) at Dec. 31, 2025   73,954,625        
Beginning balance at Dec. 31, 2025 (46,993) $ 7 617,318 (36,462) (610,921) (16,935)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,525)       (1,525)  
Issuance of common stock to directors (in shares)   5,416        
Vesting of restricted stock units (in shares)   336,372        
Vesting of restricted stock units 1,559   (8,032)     9,591
Exercise of stock options (in shares)   59,665        
Exercise of stock options 630   630      
Repurchase of common stock (in shares)   (842,896)        
Repurchase of common stock (21,808)         (21,808)
Stock-based compensation expense 8,882   8,882      
Other comprehensive gain (loss) 288     288    
Ending balance (in shares) at Mar. 31, 2026   73,513,182        
Ending balance at Mar. 31, 2026 (58,967) $ 7 618,798 (36,174) (612,446) (29,152)
Beginning balance (in shares) at Dec. 31, 2025   73,954,625        
Beginning balance at Dec. 31, 2025 (46,993) $ 7 617,318 (36,462) (610,921) (16,935)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (13,342)          
Ending balance (in shares) at Jun. 30, 2026 71,800,000 71,796,656        
Ending balance at Jun. 30, 2026 $ (105,181) $ 7 623,090 (33,624) (624,263) (70,391)
Beginning balance (in shares) at Mar. 31, 2026   73,513,182        
Beginning balance at Mar. 31, 2026 (58,967) $ 7 618,798 (36,174) (612,446) (29,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (11,817)       (11,817)  
Issuance of common stock to directors (in shares)   7,776        
Vesting of restricted stock units (in shares)   101,616        
Vesting of restricted stock units (1,303)   (3,992)     2,689
Exercise of stock options (in shares)   21,970        
Exercise of stock options $ 246   246      
Repurchase of common stock (in shares) (1,800,000) (1,847,888)        
Repurchase of common stock $ (43,928)   0     (43,928)
Stock-based compensation expense 8,038   8,038      
Other comprehensive gain (loss) $ 2,550     2,550    
Ending balance (in shares) at Jun. 30, 2026 71,800,000 71,796,656        
Ending balance at Jun. 30, 2026 $ (105,181) $ 7 $ 623,090 $ (33,624) $ (624,263) $ (70,391)